Skip to main content

Table 2 Prevalence of seropositivity to three malarial antigens in children who received seasonal malaria chemoprevention (SMC) for 2 years or for 4 years

From: Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali

 

n

%

95% CI

Unadjusted

Adjusteda

OR

95% CI

p

OR

95% CI

p

AMA1

 SMC 2 years

215

88.8

84.5–92.8

Ref

Ref

 SMC 4 years

205

95.3

92.5–98.2

2.57

1.22–5.45

0.014

3.16

1.44–6.95

0.004

MSP-142

 SMC 2 years

208

86.0

81.5–90.4

Ref

Ref

 SMC 4 years

183

85.1

80.3–90.0

0.93

0.55–1.58

0.8

1.06

0.62–1.80

0.8

CSP

 SMC 2 years

196

81.9

76.0–86.0

Ref

Ref

 SMC 4 years

197

91.2

87.0–95.4

2.57

1.43–4.59

0.001

3.14

1.70–5.76

 < 0.001

  1. SMC 2 years = received SMC for 2 years; SMC 4 years = received SMC for 4 years
  2. aadjusted for age, gender and malaria infection